{"id":"https://openalex.org/W4407976118","doi":"https://doi.org/10.1016/j.jtct.2025.01.359","title":"Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) on Treatment Outcomes in Multiple Myeloma Patients Undergoing CAR-T Cell Therapy.","display_name":"Impact of Clonal Hematopoiesis of Indeterminate Potential (CHIP) on Treatment Outcomes in Multiple Myeloma Patients Undergoing CAR-T Cell Therapy.","publication_year":2025,"publication_date":"2025-02-01","ids":{"openalex":"https://openalex.org/W4407976118","doi":"https://doi.org/10.1016/j.jtct.2025.01.359"},"language":"en","primary_location":{"id":"doi:10.1016/j.jtct.2025.01.359","doi":"https://doi.org/10.1016/j.jtct.2025.01.359","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.359","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/j.jtct.2025.01.359","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072955574","display_name":"Sophie G. Carlson","orcid":"https://orcid.org/0009-0007-6686-1494","observed_orcids":["https://orcid.org/0009-0007-6686-1494"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sophie G Carlson","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003099190","display_name":"Benjamin R. Puliafito","orcid":"https://orcid.org/0000-0003-3972-6362","observed_orcids":["https://orcid.org/0000-0003-3972-6362"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin Puliafito","raw_affiliation_strings":["Medical Oncology, Massachusetts General Hospital, Department of Medical Oncology, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Massachusetts General Hospital, Department of Medical Oncology, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Paige Brown","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paige Brown","raw_affiliation_strings":["UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027513618","display_name":"Kosuke Kawai","orcid":"https://orcid.org/0000-0002-0908-5296","observed_orcids":["https://orcid.org/0000-0002-0908-5296"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kosuke Kawai","raw_affiliation_strings":["Department of Medicine Statistics Core, UCLA David Geffen School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine Statistics Core, UCLA David Geffen School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041041491","display_name":"T. Niroshi Senaratne","orcid":"https://orcid.org/0000-0001-5595-0204","observed_orcids":["https://orcid.org/0000-0001-5595-0204"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T Niroshi Senaratne","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045924328","display_name":"Thomas D Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343052199","display_name":"Kaiser Permanente","ror":"https://ror.org/00t60zh31","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1343052199"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas D Lee","raw_affiliation_strings":["Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA","Regional Molecular Genetic & Genomic Pathology Laboratory, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]},{"raw_affiliation_string":"Regional Molecular Genetic & Genomic Pathology Laboratory, Southern California Permanente Medical Group, Kaiser Permanente, Los Angeles, CA","institution_ids":["https://openalex.org/I1343052199"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025044229","display_name":"Tasha Lotus Lin","orcid":"https://orcid.org/0000-0003-4281-4152","observed_orcids":["https://orcid.org/0000-0003-4281-4152"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tasha L Lin","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Timmerman","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041161932","display_name":"Sarah Marie Larson","orcid":"https://orcid.org/0000-0002-4335-2925","observed_orcids":["https://orcid.org/0000-0002-4335-2925"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah M Larson","raw_affiliation_strings":["Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072955574"],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":{"value":3650,"currency":"USD","value_usd":3650},"apc_paid":{"value":3650,"currency":"USD","value_usd":3650},"fwci":0.832,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.70210368,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"31","issue":"2","first_page":"S236","last_page":"S236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5874000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.5874000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.39750000834465027,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.9980000257492065},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9950000047683716},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.753000020980835},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8539999723434448},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.968999981880188},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5849999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8830000162124634},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9269999861717224},{"id":"https://openalex.org/keywords/clonal-expansion","display_name":"clonal expansion","score":0.5460000038146973},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.35100001096725464},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5540000200271606},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.6159999966621399},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.8001429438591003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5643477439880371},{"id":"https://openalex.org/C2911194787","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"CAR T-cell therapy","level":5,"score":0.5434156060218811},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4951113760471344},{"id":"https://openalex.org/C94624232","wikidata":"https://www.wikidata.org/wiki/Q3150667","display_name":"Indeterminate","level":2,"score":0.4631492495536804},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4455839693546295},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40657132863998413},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3253461718559265},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.323239266872406},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20561927556991577},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.17836475372314453},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17176324129104614},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14383026957511902},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11835789680480957},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.08352965116500854},{"id":"https://openalex.org/C202444582","wikidata":"https://www.wikidata.org/wiki/Q837863","display_name":"Pure mathematics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jtct.2025.01.359","doi":"https://doi.org/10.1016/j.jtct.2025.01.359","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.359","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jtct.2025.01.359","doi":"https://doi.org/10.1016/j.jtct.2025.01.359","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jtct.2025.01.359","pdf_url":null,"source":{"id":"https://openalex.org/S59987174","display_name":"Transplantation and Cellular Therapy","issn_l":"1083-8791","issn":["1083-8791","1523-6536","2666-6367"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transplantation and Cellular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7169649982","https://openalex.org/W4405034699","https://openalex.org/W7154509352","https://openalex.org/W3193026551","https://openalex.org/W4403498082","https://openalex.org/W3031045049","https://openalex.org/W4417010332","https://openalex.org/W4405039658","https://openalex.org/W3035594055","https://openalex.org/W2980881979"],"abstract_inverted_index":{"Introduction":[0],"Clonal":[1],"hematopoiesis":[2],"of":[3,32,78,99,108,136,169,183,213,227,285,290,364,391,400,404],"indeterminate":[4],"potential":[5],"(CHIP)":[6],"includes":[7],"hematologic":[8],"malignancy-associated":[9],"somatic":[10,130],"mutations":[11,126,140,215,258,272],"that":[12],"drive":[13],"clonal":[14],"expansion":[15],"and":[16,41,55,103,138,145,160,176,277,309,336,351,369,398],"are":[17,43],"seen":[18,394],"in":[19,58,141,201,221,298,304,328,362,418],"patients":[20,59,119,123,202,299,305,333,372,420],"without":[21,158,174,270,306,334],"myeloid":[22,113],"or":[23,111,245,414],"lymphoid":[24],"neoplasms.":[25],"In":[26],"multiple":[27,81],"myeloma":[28,82],"(MM),":[29],"the":[30,117,211,402,410],"implications":[31],"CHIP":[33,54,125,159,175,214,218,229,257,271,278,301,307,335,338,374,386,405],"on":[34,339],"chimeric":[35],"antigen":[36],"receptor":[37],"(CAR)-T":[38],"cell":[39,64,87,101,187,205,423],"outcomes":[40,57],"toxicities":[42],"not":[44,208,233,318,377,407],"well-defined.":[45],"Objectives":[46],"This":[47],"study":[48,73],"aims":[49],"to":[50,262],"explore":[51],"associations":[52],"between":[53,152,189,332,366],"clinical":[56],"with":[60,80,132,164,178,180,195,217,235,256,281,300,313,337,373,395],"MM":[61,419],"undergoing":[62,203],"CAR-T":[63,86,100,204,422],"therapy.":[65,424],"Methods":[66],"We":[67],"performed":[68],"a":[69,129,228,282,314,359,388],"retrospective,":[70],"single":[71],"center":[72,77],"at":[74,154],"UCLA":[75],"medical":[76],"adults":[79],"who":[83],"received":[84],"commercial":[85],"therapy,":[88],"had":[89,104,124],"available":[90],"NGS":[91],"data":[92],"from":[93],"bone":[94],"marrow":[95],"within":[96],"1":[97],"year":[98],"infusion,":[102],"no":[105,192,222,325],"prior":[106,170,184],"history":[107],"myelodysplastic":[109],"syndrome":[110,266],"acute":[112],"leukemia.":[114],"Results":[115],"Of":[116],"51":[118],"identified,":[120],"17":[121],"(33%)":[122],"(defined":[127],"as":[128],"mutation":[131,230],"variant":[133],"allele":[134],"frequency":[135,397],"2-40%":[137],"excluding":[139],"TP53,":[142],"KRAS,":[143],"BRAF,":[144],"EZH2).":[146],"The":[147,166,197,225,288],"average":[148],"age":[149],"was":[150,231,279,296,311,358],"comparable":[151],"groups":[153,190],"62":[155],"years":[156,162],"old":[157,163],"66":[161],"CHIP.":[165],"median":[167],"lines":[168],"therapy":[171,206],"were":[172,259],"5.35":[173],"4.76":[177],"CHIP,":[179,193],"similar":[181],"rates":[182],"autologous":[185],"stem":[186],"transplant":[188],"(70.6%":[191],"76.5%":[194],"CHIP).":[196],"overall":[198,246],"response":[199,393,411],"rate":[200],"did":[207,406],"differ":[209],"by":[210],"presence":[212,226,403],"(94%":[216],"vs.":[219,274,302,343,348,354,381],"91%":[220],"CHIP;":[223],"p=0.99).":[224],"also":[232],"associated":[234,280,312],"progression-free":[236],"survival":[237,247,417],"(PFS)":[238],"(HR":[239,249],"0.54;":[240],"95%":[241,251],"CI:":[242],"0.15-1.96;":[243],"p=0.35)":[244],"(OS)":[248],"0.41;":[250],"CI;":[252],"0.05-3.71;":[253],"p=0.43).":[254],"Patients":[255],"more":[260],"likely":[261],"develop":[263],"cytokine":[264],"release":[265],"(CRS)":[267],"than":[268],"those":[269],"(100%":[273],"65%;":[275],"p=0.004),":[276],"higher":[283,315,389],"grade":[284,399],"CRS":[286],"(p=0.04).":[287],"incidence":[289],"immune":[291],"effector":[292],"cell-associated":[293],"neurotoxicity":[294],"(ICANS)":[295],"41%":[297],"21%":[303],"(p=0.18),":[308],"again":[310],"grade,":[316],"though":[317,376],"statistically":[319,378],"significant":[320,326,379],"(p=0.19).":[321],"Despite":[322],"there":[323,357],"being":[324],"differences":[327],"absolute":[329],"neutrophil":[330],"count":[331],"days":[340,367],"28":[341],"(1.59":[342],"1.29,":[344],"p=0.42),":[345],"90":[346,368],"(2.03":[347],"0.88,":[349],"p=0.82),":[350],"120":[352,370],"(1.41":[353],"3.44,":[355],"p=0.55),":[356],"notable":[360],"increase":[361],"use":[363],"G-CSF":[365],"for":[371],"mutations,":[375],"(27%":[380],"4%;":[382],"p=0.07).":[383],"Conclusion":[384],"Although":[385],"conferred":[387],"risk":[390],"inflammatory":[392],"increased":[396],"CRS,":[401],"negatively":[408],"influence":[409],"rate,":[412],"survival,":[413],"progression":[415],"free":[416],"after":[421]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-02-27T00:00:00"}